| Filed | Form | Items | Signal | Score | Summary | Link |
|---|---|---|---|---|---|---|
| 2026-06-24 08:56 | 8-K | ["1.02", "2.01"] | merger agreement | 1.00 | Eli Lilly completed acquisition of Centessa Pharmaceuticals for $38/share cash plus CVRs via scheme of arrangement. | SEC · detail |
| 2026-06-12 16:15 | 8-K | ["5.07"] | merger agreement | 0.98 | Centessa shareholders approved acquisition by Eli Lilly subsidiary; court-sanctioned scheme of arrangement voted on June 12, 2026. | SEC · detail |
| 2026-05-22 16:15 | 8-K | ["8.01"] | merger agreement | 0.98 | Eli Lilly acquisition of Centessa Pharmaceuticals cleared HSR antitrust review; closing subject to shareholder and High Court approval. | SEC · detail |